Boja J W, Carroll F I, Rahman M A, Philip A, Lewin A H, Kuhar M J
Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, Baltimore, MD 21224.
Eur J Pharmacol. 1990 Aug 10;184(2-3):329-32. doi: 10.1016/0014-2999(90)90627-i.
Two potent cocaine analogs have been developed that have the highest known affinities for the cocaine binding site in rat striatum. Both 3 beta-(4-chlorophenyl)- (RTI-COC-31) and 3 beta-(4-methylphenyl)-tropane-2-carboxylic acid methyl ester (RTI-COC-32) compete for [3H]WIN 35,428 and [3H]mazindol binding with a IC50 that is 100 times more potent than that of (-) cocaine. Additionally, these compounds inhibit [3H]dopamine uptake with a similar, high potency. These results may lead to the development of high affinity probes for the cocaine binding site.
已经开发出两种强效可卡因类似物,它们对大鼠纹状体中可卡因结合位点具有已知的最高亲和力。3β-(4-氯苯基)-(RTI-COC-31)和3β-(4-甲基苯基)-托烷-2-羧酸甲酯(RTI-COC-32)都能与[3H]WIN 35,428和[3H]吗茚酮竞争结合,其IC50比(-)可卡因强100倍。此外,这些化合物以相似的高效力抑制[3H]多巴胺摄取。这些结果可能会导致开发出针对可卡因结合位点的高亲和力探针。